Why Companies Choose Us
The difference between a consulting engagement that produces real results and one that produces reports is the experience, focus, and commitment of the people doing the work.
Senior-Level Engagement, Every Time
When you hire Veridia, you work directly with experienced consultants who have 20+ years of individual industry experience. We don't hand off your project to junior staff or subcontractors. The people in your meetings are the people doing the work.
Medical Device & IVD Specialists — Not Generalists
Our entire practice is focused on FDA-regulated medical devices and in vitro diagnostics. We understand device-specific regulatory pathways, quality system requirements, and inspection patterns that generalist firms often miss.
Practical Execution Over Theoretical Advice
We don't produce reports and walk away. We work alongside your team to build, fix, and implement — SOPs, CAPA systems, submission documents, inspection preparation. The deliverable is results, not just recommendations.
Inspection-Tested Approach
Our methods are built from years of direct FDA inspection experience — on both sides of the table. We know what investigators look for, how they assess compliance, and what makes the difference between a clean inspection and a 483.
Scaled to Your Business Reality
Whether you're a 10-person startup or a 500-person manufacturer, we size our approach to fit your organization. No oversized consulting teams, no unnecessary overhead — just the right level of support for your situation.
Direct and Responsive Communication
You'll never wonder where your project stands. We communicate proactively, set clear expectations, and deliver on our commitments. When something changes, you hear about it right away — not at the next status meeting.
What Our Clients Say
FDA RA Group brought a level of depth and clarity we hadn't seen from other consultants. They didn't just identify our gaps — they helped us build a quality system that actually works for our team. We passed our FDA inspection with zero observations.
Rachel Harmon
VP of Quality, Avara Medical Devices
When we received a 483, we needed experienced guidance fast. FDA RA Group developed a thorough response strategy that FDA accepted without further action. Their practical knowledge and responsiveness were exactly what we needed under pressure.
David Kline
Director of Regulatory Affairs, Novient Diagnostics